4//SEC Filing
Mottola Frank 4
Accession 0001804567-25-000006
CIK 0001356576other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:39 PM ET
Size
8.7 KB
Accession
0001804567-25-000006
Insider Transaction Report
Form 4
Mottola Frank
SVP, Quality, GMP, Ops, IT
Transactions
- Sale
Common Stock
2025-09-12$45.87/sh−5,000$229,350→ 15,496 total - Exercise/Conversion
Common Stock
2025-09-12$39.40/sh+5,000$197,000→ 20,496 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-09-12−5,000→ 5,000 totalExercise: $39.40Exp: 2028-02-14→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.73 to $45.96. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]The option vests in four equal annual installments beginning on February 14, 2019 .
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001804567
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 5:39 PM ET
- Size
- 8.7 KB